Older adults with epilepsy are often managing several conditions at once like stroke, dementia, brain injury, tumors, and ...
Talking With Docs on MSN
What physicians need patients to understand about cannabidiol products
What physicians need patients to understand about cannabidiol products ...
Alex Hope and Liam Jones, who ran a Hull company, fraudulently obtained £81,000 in loans.
The National Center for Cannabis Research and Education (NCCRE) at the University of Mississippi and Southern Sky Brands announced a collaborative clinical research initiative to evaluate the effects ...
Summary: Topline results from the Phase 2 LiBBY clinical trial demonstrate that a targeted oral formulation combining cannabidiol (CBD) and tetrahydrocannabinol (THC) rapidly and significantly reduces ...
A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest top-line results from the phase 2 LiBBY (Life's End Benefits of cannaBidiol ...
The National Center for Cannabis Research and Education (NCCRE) at the University of Mississippi and Southern Sky Brands have announced a collaborative clinical research initiative to evaluate the ...
A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest ...
MarketBeat on MSN
Tilray Brands Q4 Earnings Call Highlights
The Cannabis Sector's Billion-Dollar Tax Cut Tilray Brands (NASDAQ:TLRY) reported record fiscal 2026 revenue and adjusted ...
In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.
A medically formulated THC and CBD treatment reduced agitation in a blinded trial involving people with late-stage dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results